Six months after second COVID jab ideal time for booster dose: Bharat Biotech CMD

About the nasal vaccine being developed by Bharat Biotech after its Coavaxin, Dr Krishna Ella said that the Phase 2 trials are done and data was being analysed. “We should expect it in 3-4 months,” he said, adding that Bharat Biotech was also talking to the government about using the Cowin platform for doing clinical trials.